Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria

被引:14
作者
Barennes, H
Sterlingot, H
Nagot, N
Meda, H
Kaboré, M
Sanou, M
Nacro, B
Bourée, P
Pussard, E
机构
[1] Hop Bicetre, Serv Pharmacol & Parasitol, F-94275 Le Kremlin Bicetre, France
[2] Hop Sanou Souro, Serv Pediat, Bobo Dioulasso, Burkina Faso
[3] Ctr Muraz, Bobo Dioulasso, Burkina Faso
关键词
quinine hydrochloride salt; cinchona alkaloid mixture; intrarectal administration; pharmacokinetics; childhood malaria;
D O I
10.1007/s00228-002-0546-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To compare the intrarectal bioavailabilities of two parenteral formulations of quinine most available in French- (Cinchona alkaloid mixture) and English (hydrochloride salt) -speaking areas of Africa. Methods: The pharmacokinetics of quinine was investigated in four groups of 12 children with acute Plasmodium falciparum malaria receiving 8 mg/kg quinine base every 8 h either as hydrochloride salt or Cinchona alkaloid mixture by a slow 4-h intravenous infusion or intrarectal administration. Body temperature and parasitaemia were monitored, and blood quinine concentrations were measured by means of high-performance liquid chromatography. Results: At 72 h, all the children were aparasitaemic and apyretic. Quinine C-max values were higher after intravenous infusion of the hydrochloride salt and Cinchona alkaloid mixture (6.9 +/- 1.9 mug/ml and 5.2 +/- 1.3 mug/ml) than. after intrarectal administration (3.5 +/- 1.4 mug/ml and 3.1 +/- 1.6 mug/ml), but t(max) values were similar (3.6 +/- 1.5, 4.2 +/- 1.0, 4.0 +/- 1.9, and 4.7 +/- 2.0 h, respectively). Intrarectal relative bioavailabilities of hydrochloride salt solution (57%) and Cinchona alkaloid mixture (62%) were similar. Conclusion: Whatever the parenteral formulation of quinine, the blood concentration-time profiles of quinine were similar after intrarectal administration. Intrarectal administration of hydrochloride salt solution is a possible mode of quinine delivery in remote rural areas of Africa.
引用
收藏
页码:649 / 652
页数:4
相关论文
共 10 条
[1]   Pharmacokinetics of Quinimax® suppositories in children with malaria -: A preliminary study [J].
Barennes, H ;
Verdier, F ;
Clavier, F ;
Pussard, E .
CLINICAL DRUG INVESTIGATION, 1999, 17 (04) :287-291
[2]   Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria [J].
Barennes, H ;
Pussard, E ;
Sani, AM ;
Clavier, F ;
Kahiatani, F ;
Granic, G ;
Henzel, D ;
Ravinet, L ;
Verdier, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (05) :389-395
[3]   An open randomized clinical study of intrarectal versus infused Quinimax® for the treatment of childhood cerebral malaria in Niger [J].
Barennes, H ;
Munjakazi, J ;
Verdier, F ;
Clavier, F ;
Pussard, E .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (04) :437-440
[4]   ACTIVITY OF A COMBINATION OF 3 CINCHONA BARK ALKALOIDS AGAINST PLASMODIUM-FALCIPARUM INVITRO [J].
DRUILHE, P ;
BRANDICOURT, O ;
CHONGSUPHAJAISIDDHI, T ;
BERTHE, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :250-254
[5]   APIS - A SOFTWARE FOR MODEL IDENTIFICATION, SIMULATION AND DOSAGE REGIMEN CALCULATIONS IN CLINICAL AND EXPERIMENTAL PHARMACOKINETICS [J].
ILIADIS, A ;
BROWN, AC ;
HUGGINS, ML .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1992, 38 (04) :227-239
[6]  
Karbwang Juntra, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P773
[7]   Pharmacokinetics of quinine, chloroquine and amodiaquine - Clinical implications [J].
Krishna, S ;
White, NJ .
CLINICAL PHARMACOKINETICS, 1996, 30 (04) :263-299
[8]   COMBINATION OF QUININE, QUINIDINE AND CINCHONINE FOR THE TREATMENT OF ACUTE FALCIPARUM-MALARIA - CORRELATION WITH THE SUSCEPTIBILITY OF PLASMODIUM-FALCIPARUM TO THE CINCHONA ALKALOIDS INVITRO [J].
SOWUNMI, A ;
SALAKO, LA ;
LAOYE, OJ ;
ADEROUNMU, AF .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1990, 84 (05) :626-629
[9]   PHARMACOKINETICS OF RECTAL DRUG ADMINISTRATION .1. GENERAL CONSIDERATIONS AND CLINICAL APPLICATIONS OF CENTRALLY ACTING DRUGS [J].
VANHOOGDALEM, EJ ;
DEBOER, AG ;
BREIMER, DD .
CLINICAL PHARMACOKINETICS, 1991, 21 (01) :11-26
[10]  
Zhao XJ, 1997, J PHARMACOL EXP THER, V283, P1168